Enter Note Done
Go to previous page in this tab
Session
  • Presentation | 434 - Clinical and Investigative Horizons II
  • Special Topics
  • Share Icon
    Map Icon
    Bookmark Icon
  • Efficacy And Safety Of SHR-1918, An Angiopoietin-like 3 Monoclonal Antibody, In Combination With Lipid-lowering Therapy In Patients With Suboptimally Controlled Hyperlipidemia: A Multicenter, Randomized, Double Blind, Placebo-controlled Phase 2 Trial - Xiaojie Xie
    • Schedule
    Notes
  • Location IconS100B
    434-08
    Set Timezone

Generic 'disconnected' Message
Jianan wang, Xiaojie Xie, Xiaoxia Shi, Yuming Zhang, Shuhong Su, Chengyan Jiang, Liu Miao, Junkui Wang, Daoquan Peng, Lingchun Lv, Xiaohong Chai, Suxin Luo, Yang Zheng, Shan Huang, Dan Zhu, Shangshang Liao, Meng Ren, Xiaohong Gao, Haibo Yang, Hao Zhou, Chao Lv, Min Zhu, Ying Zhu, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China
Session Type
Pathway
Education Sessions
Main Session